Commit Lozenge

Commit Lozenge, is a Nicotine Replacement Therapy produced by COPD International and manufactured by GlaxoSmithKline. Like its sibling products, Nicorette and the Nicoderm, the active ingredient is nicotine polacrilex. The Commit Lozenge comes in two strengths: 2mg and 4mg. The name appears to be derived from the Personal Commitment that is required when trying to Quit Smoking which is now required in many countries due to smoking ban. Qutting smoking requires will power. Many have tried via cold turkey.

History
Commit Lozenge was approved by the FDA in 2002 the first and only nicotine lozenge for over-the-counter (OTC) sale.

Safety issues
As with any medication, whether over-the-counter or not, there are possible side effects of use.